New Jersey Hematology Oncology Associates — Brick, New Jersey

New Jersey Hematology Oncology Associates is a clinical research site located in Brick, New Jersey, United States 08724.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

New Jersey Hematology Oncology Associates has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: HER-2 Positive Breast Cancer, Metastatic Neoplasm, Cancer.

Sponsors: MacroGenics, Harbinger Health, SOTIO a.s..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Hematology Oncology Associates?

New Jersey Hematology Oncology Associates has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Hematology Oncology Associates conducted?

New Jersey Hematology Oncology Associates has 9 clinical trials on record, with 1 currently active. Their work covers HER-2 Positive Breast Cancer, Metastatic Neoplasm, Cancer.

Is New Jersey Hematology Oncology Associates accredited by Crixeo Health?

Yes — New Jersey Hematology Oncology Associates holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New Jersey Hematology Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.